Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplantation for Hematologic Malignancies”

1,638 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,638 results

Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Not applicableStudy completedNCT05147311
What this trial is testing

Positive Psychology Intervention In HSCT

Who this might be right for
Hematologic MalignancyHematopoietic/Lymphoid CancerBlood Cancer
Brigham and Women's Hospital 72
Early research (Phase 1)Study completedNCT03393611
What this trial is testing

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Relapsed Adult Acute Myeloid+1 more
Weill Medical College of Cornell University 14
Not applicableUnknownNCT01042717
What this trial is testing

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Who this might be right for
Multiple MyelomaNon-Hodgkins Lymphoma
Shi, Patricia, M.D. 10
Testing effectiveness (Phase 2)Looking for participantsNCT06686108
What this trial is testing

Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONRelapse
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 59
Not applicableStudy completedNCT04172818
What this trial is testing

Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families

Who this might be right for
Hematopoietic/Lymphoid CancerPsychological Disorder
Centre Hospitalier Universitaire, Amiens 20
Testing effectiveness (Phase 2)Study completedNCT00793572
What this trial is testing

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Not applicableLooking for participantsNCT07500441
What this trial is testing

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Peking University People's Hospital 100
Testing effectiveness (Phase 2)UnknownNCT02568241
What this trial is testing

Interferon-α After DLI for the Prevention of Relapse

Who this might be right for
Leukemia
Peking University People's Hospital 42
Not applicableStudy completedNCT00186342
What this trial is testing

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

Who this might be right for
Acute DiseaseMyelodysplastic SyndromesLeukemia, Myeloid, Chronic+4 more
Stanford University 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05316701
What this trial is testing

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+4 more
Orca Biosystems, Inc. 187
Testing effectiveness (Phase 2)Study completedNCT04099901
What this trial is testing

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

Who this might be right for
Multiple Myeloma
Radboud University Medical Center 88
Testing effectiveness (Phase 2)UnknownNCT01894477
What this trial is testing

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia in RemissionChronic Myelomonocytic LeukemiaMinimal Residual Disease+3 more
Fred Hutchinson Cancer Center 102
Large-scale testing (Phase 3)Study completedNCT02730299
What this trial is testing

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more
Gamida Cell ltd 125
Large-scale testing (Phase 3)Study completedNCT02197221
What this trial is testing

Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 300
Large-scale testing (Phase 3)Study completedNCT00824993
What this trial is testing

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 78
Testing effectiveness (Phase 2)WithdrawnNCT06180863
What this trial is testing

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
Yale University
Not applicableStudy completedNCT04364256
What this trial is testing

Muscle Stimulation for Physical Function During Stem Cell Transplant

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
VA Office of Research and Development 46
Next Page